NEW YORK (GenomeWeb News) – Helicos Biosciences will use a $20 million senior secured credit facility from GE Healthcare Financial Services to shore up its working capital and to fund commercialization efforts, the company said today.
 
The company received an initial $10 million under the facility on Dec. 31, and it will be able to draw down the remaining $10 million through the end of June. The first $10 million will be amortized over 36 months, and Helicos will owe interest-only payments over the initial 12 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.